Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

Despite the modest revenue outlook, Pfizer’s earnings per share (EPS) forecast for 2025 is encouraging. The company projects adjusted diluted EPS of $2.80 to $3.00, representing a 2% year-over-year ...

Pfizer Earnings Preview: What to Expect. Sohini Mondal . Wed, Jul 9, 2025, ... The New York-based company is slated to announce its fiscal Q2 2025 results before the market opens on Tuesday, Aug. 5.

The New York-based company is slated to announce its fiscal Q2 2025 results before the market opens on Tuesday, Aug. 5. Ahead of the event, analysts predict Pfizer to report an adjusted EPS of $0. ...

Q2 earnings growth for the S&P 500 index of +4.7% improves to +6.7% once the Energy sector’s drag is removed from the aggregate numbers, ... Bank Earnings Outlook Improving.

Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...